Nicole M. Bouvier
- ASSISTANT PROFESSOR Medicine, Infectious Diseases
- ASSISTANT PROFESSOR Microbiology
American Board of Internal Medicine
MD, Mount Sinai School of Medicine
B.A. Magna Cum Laude, Williams College
Certificate, Columbia University Post-Baccalaureate Premedical Program
M.D. with Distinction in Research, Mount Sinai School of Medicine
Residency, Internal Medicine
Mount Sinai Hospital
Fellowship, Infectious Disease
Mount Sinai Hospital
- Watch a video featuring the Microbiology and Virology PhD Graduate School Program.
Special Citation for Fellows-in-Training
Oral Abstract Presentation, 47th Annual Meeting of the Infectious Diseases Society of America
Distinction in Research
Mount Sinai School of Medicine
Phi Beta Kappa
Gamma Chapter of Massachusetts, Williams College
Bouvier NM, Rahmat S, Pica N. Enhanced Mammalian Transmissibility of Seasonal Influenza A/H1N1 Viruses Encoding an Oseltamivir-Resistant Neuraminidase. Journal of virology 2012 Jul; 86(13).
Bouvier NM. The science of security versus the security of science [editorial]. The Journal of infectious diseases 2012 Jun; 205(11).
Seibert CW, Rahmat S, Krammer F, Palese P, Bouvier NM. Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistance. Journal of virology 2012 May; 86(9).
Pica N, Chou YY, Bouvier NM, Palese P. Transmission of influenza B viruses in the guinea pig. Journal of virology 2012 Apr; 86(8).
Pica N, Bouvier NM. Environmental factors affecting the transmission of respiratory viruses. Current opinion in virology 2012 Feb 2(1).
Bouvier NM, Lowen AC. Animal Models for Influenza Virus Pathogenesis and Transmission [review]. Viruses 2010; 2(8).
Bouvier NM, Lowen AC, Palese P. Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol. Journal of virology 2008 Oct; 82(20).
Bouvier NM, Palese P. The biology of influenza viruses. Vaccine 2008 Sep; 26 Suppl 4.
Mark-Danieli M, Laham N, Kenan-Eichler M, Castiel A, Melamed D, Landau M, Bouvier NM, Evans MJ, Bacharach E. Single point mutations in the zinc finger motifs of the human immunodeficiency virus type 1 nucleocapsid alter RNA binding specificities of the gag protein and enhance packaging and infectivity. Journal of virology 2005 Jun; 79(12).
Park MS, Shaw ML, Muñoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, García-Sastre A, Basler CF. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. Journal of virology 2003 Jan; 77(2).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Bouvier did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Annenberg Building Floor 16 Room 250 / 53A
1468 Madison Avenue
New York, NY 10029